Following extensive characterization of nelarabine-exposed AML cells, the authors compile a model in which nelarabine treatment induces R-loop (RNA:DNA hybrid) mediated replication stress activating ATR-Chk1 signaling causing upregulation of RRM2, the small subunit of RNR. This evidence concerns the gene RRM2 and acute myeloid leukemia.